Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
208.1 SEK | +0.05% | +81.66% | +63.65% |
01:40pm | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
10:28am | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.65% | 1.05B | |
+14.75% | 77.63B | |
+12.05% | 8.78B | |
+57.26% | 4.93B | |
-16.24% | 4.79B | |
+1.45% | 3.8B | |
+22.28% | 2.46B | |
-26.19% | 2.2B | |
+16.04% | 2.1B | |
-37.26% | 1.96B |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Transcript : Calliditas Therapeutics AB, Q1 2021 Earnings Call, May 18, 2021